Quantitation of terminal erythroid differentiation in normal and anemic mouse models
. | Pro (%) . | Baso (%) . | Poly (%) . | Ortho (%) . |
---|---|---|---|---|
WT (n = 20) | ||||
Bone marrow | 6.1 ± 1.2 | 12.7 ± 1.6 | 27.7 ± 1.4 | 53.1 ± 3.0 |
Spleen | Very low level of erythropoiesis | |||
4.1R KO (n = 6) | ||||
Bone marrow | 6.5 ± 0.5 | 13.9 ± 1.2 | 27.8 ± 1.4 | 52.2 ± 2.2 |
Spleen | 5.5 ± 1.0 | 12.7 ± 1.7 | 27.7 ± 1.8 | 54.2 ± 2.7 |
Phlebotomy-induced anemia (n = 6) | ||||
Bone marrow | 6.9 ± 1.1 | 14.3 ± 1.3 | 28.4 ± 2.0 | 52.0 ± 3.5 |
Spleen | 7.0 ± 1.1 | 13.7 ± 2.0 | 26.3 ± 4.9 | 50.5 ± 5.4 |
Hbbth1/th1 (PBS-treated, n = 6) | ||||
Bone marrow | 4.4 ± 0.3* | 15.5 ± 1.5† | 26.7 ± 0.9 | 53.5 ± 1.3 |
Spleen | 4.7 ± 1.1‡ | 15.1 ± 4.7§ | 26.6 ± 3.0 | 53.6 ± 8.4 |
Hbbth1/th1 (transferrin-treated n = 6) | ||||
Bone marrow | 6.6 ± 0.8 | 13.9 ± 2.7 | 25.6 ± 2.2 | 51.3 ± 1.5 |
Spleen | Very low level of erythropoiesis |
. | Pro (%) . | Baso (%) . | Poly (%) . | Ortho (%) . |
---|---|---|---|---|
WT (n = 20) | ||||
Bone marrow | 6.1 ± 1.2 | 12.7 ± 1.6 | 27.7 ± 1.4 | 53.1 ± 3.0 |
Spleen | Very low level of erythropoiesis | |||
4.1R KO (n = 6) | ||||
Bone marrow | 6.5 ± 0.5 | 13.9 ± 1.2 | 27.8 ± 1.4 | 52.2 ± 2.2 |
Spleen | 5.5 ± 1.0 | 12.7 ± 1.7 | 27.7 ± 1.8 | 54.2 ± 2.7 |
Phlebotomy-induced anemia (n = 6) | ||||
Bone marrow | 6.9 ± 1.1 | 14.3 ± 1.3 | 28.4 ± 2.0 | 52.0 ± 3.5 |
Spleen | 7.0 ± 1.1 | 13.7 ± 2.0 | 26.3 ± 4.9 | 50.5 ± 5.4 |
Hbbth1/th1 (PBS-treated, n = 6) | ||||
Bone marrow | 4.4 ± 0.3* | 15.5 ± 1.5† | 26.7 ± 0.9 | 53.5 ± 1.3 |
Spleen | 4.7 ± 1.1‡ | 15.1 ± 4.7§ | 26.6 ± 3.0 | 53.6 ± 8.4 |
Hbbth1/th1 (transferrin-treated n = 6) | ||||
Bone marrow | 6.6 ± 0.8 | 13.9 ± 2.7 | 25.6 ± 2.2 | 51.3 ± 1.5 |
Spleen | Very low level of erythropoiesis |